Safety and Tolerability of SHR-1316 in Subjects With Advanced Tumors

NCT03474289 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumor

Interventions

DRUG: SHR-1316

Sponsor

Jiangsu HengRui Medicine Co., Ltd.